Synta Pharmaceuticals Corp. (SNTA) Scheduled to Post Quarterly Earnings on Monday
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is set to issue its quarterly earnings data on Monday, November 4th. Individual that are interested in registering for the company’s earnings conference call can do so using this link.
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) opened at 4.54 on Friday. Synta Pharmaceuticals Corp. has a one year low of $3.76 and a one year high of $11.88. The stock has a 50-day moving average of $6.36 and a 200-day moving average of $6.47. The company’s market cap is $313.5 million.
A number of analysts have recently weighed in on SNTA shares. Analysts at JMP Securities raised their price target on shares of Synta Pharmaceuticals Corp. from $11.00 to $14.00 in a research note to investors on Monday. They now have a “market outperform” rating on the stock. Analysts at Jefferies Group reiterated a “positive” rating on shares of Synta Pharmaceuticals Corp. in a research note to investors on Monday. They now have a $20.00 price target on the stock, down previously from $22.00. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $16.40.
Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.